ArticleAngewandte Chemie (International ed. in English)2026
Semi-Reduction of Allenes to Access Deuterated Allylic Isotopomers, Isotopologs and Enantioisotopomers.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optical resolution of H/D isotopic chirality via asymmetric C-H amination.Science advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Selectively deuterated compounds represent high value synthetic targets with applications across many scientific disciplines. Despite their importance, reactions that enable access to products precisely deuterated at an allylic position with complete control over the degree of deuteration are extremely rare. In fact, the high enantiopurity synthesis of enantioisotopomers owing their chirality solely to hydrogen isotopes at an allylic position has remained elusive to date. Herein, we report a modular Cu-catalyzed semi-reductive deuteration of allenes to access a broad scope of small molecules, drug analogs, and natural product analogs precisely deuterated at allylic positions. The semi-reduction strategy has been applied to access a range of precisely labeled d1-, d2-, d3-, d5-, and d7-isotopologs. In this work, we disclose the first high enantiopurity synthesis of allylic-d1 enantioisotopomers, along with a highly accurate and precise analysis for enantiomeric excess (EE) determination and assignment of absolute configuration (AC) using molecular rotational resonance (MRR) spectroscopy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.